AgomAb Therapeutics NV American Depositary Shares share price logo

AgomAb Therapeutics NV American Depositary Shares

NASDAQ: AGMB

Small Cap

$11.95

-0.23

(-1.89%)

as on

AgomAb Therapeutics NV American Depositary Shares Stock Performance

as on May 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $11.47
    $12.44
    downward going graph

    4.02%

    Downside

    4.10%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

AgomAb Therapeutics NV American Depositary Shares share price movements today

Previous Close
$12.18
Open
$12.15
Volume
160.9K
Day's Low - High
$11.47 - $12.44

AgomAb Therapeutics NV American Depositary Shares Historical Returns

1 Month Return
+ 15.56 %
3 Month Return
-22.22 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

AgomAb Therapeutics NV American Depositary Shares Stock Fundamentals & Key Indicators

Check AgomAb Therapeutics NV American Depositary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$597.4M

EPS (TTM)

-1.8325

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-39.22%

AgomAb Therapeutics NV American Depositary Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of AgomAb Therapeutics NV American Depositary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$597.4MNANA0.00%
BUY$39.4B113.59%74.1312.55%
NA$32.2BNA70.468.94%
BUY$109.1B104.61%25.5135.51%
BUY$74.9B40.55%17.4529.65%

Indian Investors' Interest in AgomAb Therapeutics NV American Depositary Shares Stock

Search interest for AgomAb Therapeutics NV American Depositary Shares Stock has decreased by -25% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-25% versus previous 30 day period

AgomAb Therapeutics NV American Depositary Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2024
Dec 2025
Total Revenue
-
-
Gross Profit
-
-
Operating Income
-11
-16
EBITDA
-11
-
Interest Expense
0
0
Depreciation
0
0
Income Before Tax
-11
-17
Income Tax Expense
0
-
Net Income
-12
-17
Net Profit Margin
0.00%
0.00%

AgomAb Therapeutics NV American Depositary Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-22
-31
-48
-48
EBITDA
-10
-11
-45
-45
Interest Expense
0
0
0
0
Depreciation
0
0
0
0
Income Before Tax
-10
-12
-46
-46
Income Tax Expense
-2
0
0
0
Net Income
-8
-12
-48
-46
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

AgomAb Therapeutics NV American Depositary Shares Quarterly Cash Flow

All numbers in Millions USD

Dec 2025
Mar 2026
Net Income
-17
-11
Operating Cash Flow
-13
-12
Investing Cash Flow
-
0
Financing Cash Flow
0
81
Change in Cash
-43
68

AgomAb Therapeutics NV American Depositary Shares Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-46
-62
Operating Cash Flow
-24
-46
-51
Investing Cash Flow
-
-
-
Financing Cash Flow
79
96
0
Change in Cash
94
49
-85

Insights on AgomAb Therapeutics NV American Depositary Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, AGMB stock has moved up by 16.9%

About AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs. The company's product pipeline includes Ontunisertib (AGMB-129), an oral gastrointestinal-restricted small molecule inhibitor of ALK5 or TGFßR1 for the treatment of Fibrostenosing Crohn's disease, which is in Phase 2a clinical trials; and AGMB-447, an inhaled small molecule inhibitor of ALK5 or TGFßR1 for the treatment of idiopathic pulmonary fibrosis that is in Phase 1 clinical trials. It also develops AGMB-101, a HGF-mimetic monoclonal antibody that acts through agonism or stimulation of the MET receptor and has demonstrated antifibrotic and regenerative activity in preclinical models. The company was incorporated in 2017 and is headquartered in Antwerp, Belgium.
OrganisationAgomAb Therapeutics NV American Depositary Shares
HeadquartersPosthoflei 1/6, Antwerp, Belgium, 2600
IndustryBiotechnology
CEODr. Tim Knotnerus MSc, Ph.D.
E-voting on sharesClick here to vote

Key Management of AgomAb Therapeutics NV American Depositary Shares

Name

Title

Dr. Philippe Wiesel M.D.

Chief Medical Officer

Dr. Paul Van Der Horst Ph.D.

Chief Business Officer

Dr. Andrea Sáez Borderías Ph.D.

Chief Development Officer

Dr. Tim Knotnerus MSc, Ph.D.

CEO & Executive Director

Mr. Paolo Michieli Ph.D.

Founder, Senior Advisor & Member of Scientific Advisory Board

Mr. Pierre Kemula B.Sc.

Chief Financial Officer

Sofie Van Gijsel

Vice President of Investor Relations

Ms. Ellen Lefever

General Counsel

FAQs

What is AgomAb Therapeutics NV American Depositary Shares share price today?

AgomAb Therapeutics NV American Depositary Shares share price today is $11.95 as on at the close of the market. AgomAb Therapeutics NV American Depositary Shares share today touched a day high of $12.44 and a low of $11.47.

What is the 52 week high and 52 week low for AgomAb Therapeutics NV American Depositary Shares share?

AgomAb Therapeutics NV American Depositary Shares share touched a 52 week high of $ on and a 52 week low of $ on . AgomAb Therapeutics NV American Depositary Shares stock price today i.e. is closed at $11.95,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is AgomAb Therapeutics NV American Depositary Shares's market capitalisation today?

AgomAb Therapeutics NV American Depositary Shares market capitalisation is $0.00T as on .

How to invest in AgomAb Therapeutics NV American Depositary Shares Stock (AGMB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for AgomAb Therapeutics NV American Depositary Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in AgomAb Therapeutics NV American Depositary Shares Shares that will get you 0.1255 shares as per AgomAb Therapeutics NV American Depositary Shares share price of $11.95 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy AgomAb Therapeutics NV American Depositary Shares Stock (AGMB) from India?

Indian investors can start investing in AgomAb Therapeutics NV American Depositary Shares (AGMB) shares with as little as ₹95.618 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in AgomAb Therapeutics NV American Depositary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on AgomAb Therapeutics NV American Depositary Shares share’s latest price of $11.95 as on May 13, 2026 at 1:29 am IST, you will get 0.8368 shares of AgomAb Therapeutics NV American Depositary Shares. Learn more about fractional shares .